S100A11 and neoplasm: Pan-cancer analysis was first performed and revealed that S100A11 was differentially expressed in a variety of malignant tumor tissues (Figure 6A), subsequent bioinformatics analysis using our TCGA-COAD dataset showed that S100A11 levels were notably increased in colon cancer tissues compared to normal tissues.